Currently out of the existing stock ratings of Matthew Borsch, 80 are a BUY (57.14%), 57 are a HOLD (40.71%), 3 are a SELL (2.14%).

Matthew Borsch

Work Performance Price Targets & Ratings Chart

Analyst Matthew Borsch, currently employed carries an average stock price target met ratio of 80.98% that have a potential upside of 17.89% achieved within 253 days. Previously, Matthew Borsch worked at GOLDMAN SACHS.

Matthew Borsch’s has documented 281 price targets and ratings displayed on 18 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on MD, Mednax at 10-Aug-2022.

Wall Street Analyst Matthew Borsch

Analyst best performing recommendations are on AGTI (AGILITI).
The best stock recommendation documented was for HCA (HCA HOLDINGS) at 7/13/2020. The price target of $100 was fulfilled within 2 days with a profit of $6.05 (6.44%) receiving and performance score of 32.2.

Average potential price target upside

of $69.58 (22.9%) on ELV (ELEVANCE HEALTH).
of $64 (20.72%) on ANTM (ANTHEM).
of $56.49 (22.47%) on UNH (UNITEDHEALTH GROUP ORPORATED).

ACHC Acadia Healthcare Company AMED Amedisys ANTM Anthem CI Cigna Corp CNC Centene Corp CVS CVS Health Corp HCA HCA Holdings HUM Humana MD Mednax MOH Molina Healthcare UHS Universal Health Services UNH UnitedHealth Group orporated WCG WellCare Health Plans EHC Encompass Health Corp ELV Elevance Health AGTI Agiliti AVAH Aveanna Healthcare Holdings ADUS Addus HomeCare

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sarah James (CANTOR FITZGERALD)